Navigation Links
Research Brings New Hope to Multiple Sclerosis Patients
Date:2/18/2009

the disease who take natalizumab.

"If something were to go wrong, now there is a demonstrated method to remove the drug from the body and help the patient fight PML," Goodwin says.

The National Multiple Sclerosis Society estimates 400,000 people in the United States have MS. There is no cure for multiple sclerosis though there are several drugs that can slow or stop its progress. Symptoms can include blurred vision, loss of coordination and short-term or long-term memory loss.

Aurora Health Care is a not-for-profit health care provider and a national leader in efforts to improve the quality of health care. Aurora offers care at sites in more than 90 communities throughout eastern Wisconsin.

Aurora's online newsroom: http://www.aurora.org/newsroom

The Regional MS Center: www.aurora.org/MS


'/>"/>
SOURCE Aurora St. Luke's Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Study calls for increased research in flu transmission to prepare for pandemic flu outbreak
2. Research increases possibilities of personalizing treatment of infant osteosarcoma
3. Two Scientists Honored with MetLife Foundation Awards for Medical Research in Alzheimers Disease
4. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
5. Apple's iPod Touch Joins the iPhone as a Stuttering Therapy Tool At Hollins Communications Research Institute
6. Rice Universitys Baker Institute experts available to discuss stem cell research, recommendations
7. eResearchTechnology, Inc. to Announce Fourth Quarter and Full Year 2008 Results on February 26, 2009
8. National Pharmaceutical Council on Economic Stimulus Package: Comparative Effectiveness Research Funding Should Target Improvements in Quality of Patient Care
9. OHSU vaccine research targets HIV in the slower, early stage of infection
10. American Association for Cancer Research lauds Senator Arlen Specter
11. In flurry of studies, researcher details role of apples in inhibiting breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Portland, Ore. (PRWEB) February 26, 2015 ... care services, celebrated its launch to its first ... Solutions employees and their covered dependents. , ... for health care services, combining real-time price transparency ... for a variety of routine health care services ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 In a nested-case ... of the world with a relatively low incidence of liver ... liver cancer, according to a new study published February ... Institute. , Previous studies have reported this association but ... high liver cancer incidence rate, such as Asia. Katherine A. ...
(Date:2/26/2015)... The Reproductive Science Center of New Jersey ... in Lawrenceville, NJ. , Dr. Ziegler and ... physicians, and NJ Top Docs, have been recognized for ... of infertility and reproductive medicine. This dedicated team of ... providing current, high quality medical treatments to their patients ...
(Date:2/26/2015)... Texas (PRWEB) February 26, 2015 The ... enabled local pastor and Central Texas resident John Short to ... much, he has set out to climb Mt. Kilimanjaro, the ... help stop human trafficking. , Starting in his late 20s, ... and eventually his hip bones and sockets were bone on ...
(Date:2/26/2015)... Eating disorders are serious, life-threatening illnesses ... response to emerging research regarding eating disorders in ... Eating Disorders Awareness Week, the Society for Adolescent ... for the medical management of restrictive eating disorders ... approach to assessing the degree of malnutrition and ...
Breaking Medicine News(10 mins):Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 2Health News:SpendWell Launches New Online Health Care Marketplace to Large Employer Group 3Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 2Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 3
... recently announced this years Open Senior,Division winner in ... Bachmann was one of five participants in the ... and researchers from the Prince of,Wales Hospital and ... of her studies, UNSW PhD student Ms Bachmann,presented ...
... (OTC,Bulletin Board: NNTN) http://www.naturalnutritioninc.com announced today ... D line of new products. The,company,s primary operating ... Gel Caps, with 1,000 IU Vitamin D,along with ... recent article in Best Life, October, 2007, said ...
... Measuring the Wrong Things?, NEW YORK and ... ensure maximum return on investment, sales force effectiveness,is ... industry. Reports,have shown that while sales forces represent ... on this investment has declined sharply in,recent years. ...
... Excaliard closes $15.5 million Series A financing from ... ProQuest Investments and RiverVest Venture ... 27 /PRNewswire-FirstCall/,-- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... collaboration to discover and develop antisense,drugs for the ...
... $1 Million to ... Pharmacopeia, ... innovator in the discovery and development of novel,small molecule therapeutics, announced ... its alliance with GlaxoSmithKline (NYSE:,GSK), through its collaboration with the Center ...
... Society of Hematology ... (ASH) Annual Meeting, SEATTLE, ... today announced it intends to utilize the,results of the phase III ... for submission to the United States Food,and Drug Administration (FDA) for ...
Cached Medicine News:Health News:Natural Nutrition to Launch New Vegetarian Vitamin D Line of Products 2Health News:New Report Examines Pharmaceutical Sales Force Effectiveness 2Health News:New Report Examines Pharmaceutical Sales Force Effectiveness 3Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 2Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 3Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 4Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 5Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 2Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 3Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 4Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 5Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 2Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 3Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 4Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 5Health News:Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008 6
(Date:2/26/2015)... Feb. 26, 2015  IRIDEX Corporation (NASDAQ: IRIX ... and full year 2014 financial results after the market closes ... the release, the Company will host a conference call with ... Thursday, March 5, 2015 to discuss the ... Interested parties may access the live conference call via telephone ...
(Date:2/26/2015)... DALLAS , February 26, 2015 ... EU Outlook 2015: First -In- Class Innovations and ... Business for Large Cap Pharmaceutical Companies research report ... According to this Global Pharma US ... divested as productivity measurements, divestment of non-core assets ...
(Date:2/26/2015)... 2015 The report, "Bottled ... Filler, Capper, Blow molder, Shrink wrapper), Technology (RO, ... Sparkling) & Region - Trends & Forecasts to ... bottled water processing market with analyses and projection ... value. It also identifies the driving and restraining ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4
... YORK, Jan. 13, 2011 Reportlinker.com announces that ... its catalogue: Merck & Co., ... IntroductionThis analysis examines the ... in the prescription pharmaceutical sector. The profile encompasses ...
... Codexis, Inc. (Nasdaq: CDXS) today announced the company will host ... at 4:30 p.m. Eastern Time to discuss its fourth quarter ... call and webcast will follow the release of fourth quarter ... call will be available approximately one hour after the call ...
Cached Medicine Technology:Reportlinker Adds Merck & Co., Inc.: PharmaVitae Profile 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: